Leveljump Healthcare Corp.
In connection with a continuous disclosure review by Staff of the Ontario Securities Commission, the Issuer has amended and refiled the Management’s Discussion and Analysis (MD&A) and the Annual Information Form for the financial year ended December 31, 2023 to address several disclosure deficiencies and provide additional clarification. In addition, the interim financial statements for the periods ending March 31, 2024 and June 30, 2024 were amended and refiled to correct errors in the application of International Financial Reporting Standards (IFRS) and enhance compliance with certain disclosure requirements of IFRS; the accompanying MD&As were also amended and restated to include corrective disclosure. As a result of the corrective disclosure re-filings the Issuer also re-filed certifications of interim and annual filings for financial statements and MD&A in compliance with National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings.